logo

For the Inventor, By the Inventor

Schwaig, Germany

Stefan Szelényi

This inventor holds 6 USPTO granted patents. Top assignee: Arzneimittelwerk Dresden Gmbh. Active years: 2001-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stefan Szelényi. Retrieved from https://idiyas.com/inventor/stefan-szelandeacutenyi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 16.7

Average Co-Inventor Count = 7.3

ph-index = 5

Forward Citations = 51(Granted Patents)


Company Filing History:

goldMedal6 out of 39 
 
Arzneimittelwerk Dresden Gmbh
 patents

Years Active: 2001-2003

Loading Chart...
6 patents (USPTO):Explore Patents
1. 6613794 - Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation (2003-09-02),
2. 6602890 - Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation (2003-08-05),
3. 6545158 - Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation (2003-04-08),
4. 6545025 - Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation (2003-04-08),
5. 6465465 - Process for the treatment of erectile dysfunction and product therefor (2002-10-15),
6. 6251923 - Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and process for their preparation (2001-06-26),

Title: The Innovative Mind of Stefan Szelényi

Introduction

Stefan Szelényi, an accomplished inventor residing in Schwaig, Germany, has made significant contributions to the field of medicinal chemistry. With six patents to his name, Szelényi demonstrates a deep commitment to innovation and the advancement of pharmaceutical research.

Latest Patents

Among his latest inventions is a patent titled "Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation." This innovative work focuses on the development of compounds that have potential applications in treating various diseases by modifying specific enzymatic pathways.

Career Highlights

Stefan Szelényi is a key figure at Arzneimittelwerk Dresden GmbH, a pharmaceutical company known for its dedication to research and development. His work at the company emphasizes the importance of innovation in creating effective medicinal products and therapies.

Collaborations

Throughout his career, Szelényi has collaborated with accomplished colleagues such as Norbert Höfgen and Ute Egerland. These partnerships not only highlight the collective effort required in the field of invention but also underscore the importance of teamwork in successful research endeavors.

Conclusion

In summary, Stefan Szelényi exemplifies the spirit of innovation and dedication to improving healthcare through his inventions. With his ongoing contributions to the field of medicinal chemistry, he continues to inspire future generations of inventors and researchers dedicated to creating significant advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…